Mesoblast (MESO) Profit After Tax Growth (1y) (2016 - 2023)
Mesoblast (MESO) Profit After Tax Growth (1y) (2016 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 17,802.13% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 59.59% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -107.76% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 111.59% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Mesoblast | 19.81 Bn | 19.68 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 12.01% |
| Mar 31, 2023 | -12.65% |
| Dec 31, 2022 | -5.64% |
| Sep 30, 2022 | -25.40% |
| Jun 30, 2022 | -630.69% |
| Mar 31, 2022 | 180.21% |
| Dec 31, 2021 | 201.59% |
| Sep 30, 2021 | 189.84% |
| Jun 30, 2021 | 38.31% |
| Mar 31, 2021 | -54.56% |
| Dec 31, 2020 | 4.60% |
| Sep 30, 2020 | -440.80% |
| Jun 30, 2020 | -50.05% |
| Mar 31, 2020 | 36.64% |
| Dec 31, 2019 | 2.24% |
| Sep 30, 2019 | -63.30% |
| Jun 30, 2019 | -9.37% |
| Mar 31, 2019 | -10.63% |
| Dec 31, 2018 | -184.98% |
| Sep 30, 2018 | 303.72% |